Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
1110.6000
2.60
(
0.23
%)
NSE
Jan 01, 2026
09:59 AM
New 52W High in past week
Volume:
400.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
25 Jan 2024
1110.60
0.23%
Operating deleverage drags earnings
Buy:
Laurus Labs Ltd.
by
Motilal Oswal
Target: 440
Motilal Oswal
Number of FII/FPI investors increased from 293 to 340 in Sep 2025 qtr.
More from Laurus Labs Ltd.
Recommended
Market closes higher amid strong buying in steel stocks
Trendlyne Marketwatch |
31 Dec 2025, 04:01PM
2025 turns selective on returns: Themes outperform while headline indices stall
The Baseline |
31 Dec 2025, 03:05PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020, 12:02PM